The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells
Open accessAbstract
Human natural killer (NK) cells express several killer cell immunoglobulin (Ig)-like receptors (KIRs) that inhibit their cytotoxicity upon recognition of human histocompatibility leukocyte antigen (HLA) class I molecules on target cells. Additional members of the KIR family, including some that deliver activation signals, have unknown ligand specificity and function. One such KIR, denoted KIR2DL4, is structurally divergent from other KIRs in the configuration of its two extracellular Ig domains and of its transmembrane and cytoplasmic domains. Here we show that recombinant soluble KIR2DL4 binds to cells expressing HLA-G but not to cells expressing other HLA class I molecules. Unlike other HLA class I–specific KIRs, which are clonally distributed on NK cells, KIR2DL4 is expressed at the surface of all NK cells. Furthermore, functional transfer of KIR2DL4 into the cell line NK-92 resulted in inhibition of lysis of target cells that express HLA-G, but not target cells that express other class I molecules including HLA-E. Therefore, given that HLA-G expression is restricted to fetal trophoblast cells, KIR2DL4 may provide important signals to maternal NK decidual cells that interact with trophoblast cells at the maternal–fetal interface during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Colonna, M., Navarro, F., Bellón, T., Llano, M., García, P., Samaridis, J., Angman, L., Cella, M., & López-Botet, M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.11.1809 · Cited by 950
Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
Lanier, L. L., Corliss, B. C., Wu, J., Leong, C., & Phillips, J. H. (1998) · Nature · doi:10.1038/35642 · Cited by 904
RECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80393-3 · Cited by 732
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
Gong, J.-H., Maki, G., & Klingemann, H.-G. (1994) · PubMed · Cited by 723
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 559
Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., & Geraghty, D. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4951 · Cited by 505
Braud, V., Yvonne Jones, E., & McMichael, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270517 · Cited by 502
Colonna, M., Samaridis, J., Cella, M., Ångman, L., Allen, R. L., O’Callaghan, C. A., Dunbar, P. R., Ogg, G. S., Cerundolo, V., & Rolink, A. G. (1998) · PubMed · Cited by 499
Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells
Pazmany, L., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Reyburn, H. T., & Strominger, J. L. (1996) · Science · doi:10.1126/science.274.5288.792 · Cited by 497
Colonna, M., Samaridis, J., Cella, M., Angman, L., Allen, R. L., O’Callaghan, C. A., Dunbar, R., Ogg, G. S., Cerundolo, V., & Rolink, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3096 · Cited by 457
Navarro, F., Llano, M., Bellón, T., Colonna, M., Geraghty, D. E., & López-Botet, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01<277::aid-immu277>3.0.co;2-4 · Cited by 366
A human killer inhibitory receptor specific for HLA-A1,2
Döhring, C., Scheidegger, D., Samaridis, J., Cella, M., & Colonna, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3098 · Cited by 349
Wagtmann, N., Rajagopalan, S., Winter, C. C., Peruui, M., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90069-1 · Cited by 335
Self-citationLy-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · PubMed · Cited by 277
Cutting Edge: Ly-49D and Ly-49H Associate with Mouse DAP12 and Form Activating Receptors
Smith, K. M., Wu, J., Bakker, A. B. H., Phillips, J. H., & Lanier, L. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.7 · Cited by 249
Phillips, J. H., Chang, C., Mattson, J., Gumperz, J. E., Parham, P., & Lanier, L. L. (1996) · Immunity · doi:10.1016/s1074-7613(00)80492-6 · Cited by 185
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · PubMed · Cited by 173
Pérez‐Villar, J. J., Melero, I., Navarro, F., Carretero, M., Bellón, T., Llano, M., Colonna, M., Geraghty, D. E., & López‐Botet, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.12.5736 · Cited by 169
Arase, N., Arase, H., Park, S. Y., Ohno, H., Ra, C., & Saito, T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.12.1957 · Cited by 163
Nakajima, H., Samaridis, J., Ångman, L., & Colonna, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.5 · Cited by 152
Evaluation of trophoblast HLA‐G antigen with a specific monoclonal antibody
Loke, Y. W., King, A., Burrows, T. D., Gardner, L., Bowen, M., Hiby, S. E., Howlett, S., Holmes, N., & Jacobs, D. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02852.x · Cited by 142
McVay (1996) · doi:10.1084/jem.184.4.1585 · Cited by 138
Cell surface phenotype of a cloned line of human natural killer cells.
Kornbluth, J., Flomenberg, N., & Dupont, B. (1982) · The Journal of Immunology · doi:10.4049/jimmunol.129.6.2831 · Cited by 126
Selvakumar, A., Steffens, U., & Dupont, B. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02647.x · Cited by 119
Pende, D., Sivori, S., Accame, L., Pareti, L., Falco, M., Geraghty, D. E., Bouteiller, P. P. L., Moretta, L., & Moretta, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270809 · Cited by 91
Immunology of human placental implantation: clinical implications of our current understanding
Loke, Y. W., & King, A. (1997) · Molecular Medicine Today · doi:10.1016/s1357-4310(97)01011-3 · Cited by 80
Rojo, S., Wagtmann, N. R., & Long, E. O. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270231 · Cited by 65
Self-citation
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Natural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E., & Rajagopalan, S. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075005 · Cited by 1,217
Self-citationMHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Metadata
- Authors
- Rajagopalan, S., & Long, E. O.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-04-05
- Volume
- 189
- Issue
- 7
- Pages
- 1093-1100
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2112179844
- Cited by
- 726
- References
- 32
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.